AABB participates in a variety of meetings and collaborations:
Meeting Summary between AABB and the European Commission (DG SANTE B4)
AABB and the ISCT have formed a Joint Working Group, as a collaborative effort to identify and facilitate project(s) of common interest to both organizations.
AABB/ISCT Working Group Update - 4/4/19
The Cellular Therapy FDA Liaison Meeting brings together representatives from the cellular therapy community with FDA and other relevant federal government agencies to exchange information on topics of mutual interest.
FDA Liaison Meeting - 11/19/24
FDA Liaison Meeting - 12/08/23
FDA Liaison Meeting - 11/15/21
FDA Liaison Meeting - 11/21/19
FDA Liaison Meeting - 3/05/19
FDA Liaison Meeting - 1/30/18
FDA Liaison Meeting - 10/19/16
2018 Center for Biologics Evaluation and Research Science Symposium
Days 1 and 2 videos are available
Ciltacabtagene Autoleucel Shows Benefits for Patients With High-Risk Smoldering Multiple Myeloma
April 29, 2026
FDA Approves First Gene Therapy for Genetic Hearing Loss
April 28, 2026
April 28, 2026